Pharma-Bio Industry Generates $80 Billion in New Plant Construction across Globe, an Industrial Info Market Brief

A strong industry before the era of COVID-19, the Pharmaceutical-Biotech Industry is on a worldwide new plant-building spree. A recent survey of active new-build reports reveals nearly 1,300 facilities worth more than $80 billion for initial investment are in various stages of planning, engineering and construction. These facilities encompass everything from Q-tips to advanced biologicals, and can be found in virtually every corner of the world.

The lion's share of the investment is for actual drug production (ingredients and final formulations), with an equally impressive amount for research and development in both the commercial and public sectors.